MRI in diabetes: First results

American Journal of Roentgenology

Volumn 193, Issue 2, 2009, Pages 295-303

  Medarova, Zdravka ^a   Moore, Anna ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cell mass; Autoimmune attack; Diabetes; Islet vasculature; MRI; Noninvasive imaging

Indexed keywords

CONTRAST MEDIUM; COPOLYMER; DEXTRAN; GADOLINIUM; GADOLINIUM PENTETATE; IRON OXIDE; MACROGOL; MANGANESE; NANOPARTICLE; PEPTIDE; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

AUTOIMMUNITY; CELL FUNCTION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE COURSE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MAGNETIC RESONANCE ANGIOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BIOPSY; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; VASCULARIZATION;

ANIMALS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LYMPHOCYTES; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MICE;

EID: 68149179334     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.2156     Document Type: Review

References (71)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-110 (Pubitemid 36042113)
2. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619-633
3. Imagawa A, Hanafusa T, Tamura S, et al. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001; 50:1269-1273 (Pubitemid 32500158)
4. Medarova Z, Moore A. Cellular and molecular imaging of the diabetic pancreas. In: Modo M, Bulte J, eds. Molecular and cellular MR imaging. Boca Raton, FL: CRC Press, Taylor & Francis Group, 2007:343-369
5. Moore A, Sun PZ, Cory D, Hogemann D, Weissleder R, Lipes MA. MRI of insulitis in autoimmune diabetes. Magn Reson Med 2002; 47:751-758
6. Billotey C, Aspord C, Beuf O, et al. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging. Radiology 2005; 236:579-587 (Pubitemid 41023443)
7. Santamaria P, Utsugi T, Park BJ, Averill N, Kawazu S, Yoon JW. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. J Immunol 1995; 154:2494-2503
8. Verdaguer J, Yoon JW, Anderson B, et al. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. J Immunol 1996; 157:4726-4735 (Pubitemid 126449398)
9. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997; 186:1663-1676 (Pubitemid 27506280)
10. DiLorenzo TP, Graser RT, Ono T, et al. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc Natl Acad Sci USA 1998; 95:12538-12543 (Pubitemid 28483800)
11. Anderson B, Park BJ, Verdaguer J, Amrani A, Santamaria P. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes. Proc Natl Acad Sci USA 1999; 96:9311-9316 (Pubitemid 29374751)
12. Moore A, Grimm J, Han B, Santamaria P. Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time. Diabetes 2004; 53:1459-1466 (Pubitemid 38697657)
13. Medarova Z, Tsai S, Evgenov N, Santamaria P, Moore A. In vivo imaging of a diabetogenic CD8+ T cell response during type 1 diabetes progression. Magn Reson Med 2008; 59:712-720
14. Weir GC, Bonner-Weir S, Leahy JL. Islet mass and function in diabetes and transplantation. Diabetes 1990; 39:401-405 (Pubitemid 20111419)
15. Woods M, Zhang S, Sherry AD. Toward the design of MR agents for imaging beta-cell function. Curr Med Chem Immunol Endocr Metab Agents 2004; 4:349-369 (Pubitemid 39549454)
16. Gimi B, Leoni L, Oberholzer J, et al. Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant 2006; 15:195-203 (Pubitemid 43726195)
17. Antkowiak PF, Tersey SA, Carter JD, et al. Noninvasive assessment of pancreatic β-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Metab 2009; 296:E573-E578
18. Hanaoka K, Kikuchi K, Urano Y, et al. Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc ion. Chem Biol 2002; 9:1027-1032 (Pubitemid 35273723)
19. Major JL, Parigi G, Luchinat C, Meade TJ. The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc Natl Acad Sci USA 2007; 104:13881-13886 (Pubitemid 350003305)
20. Zhang X, Lovejoy KS, Jasanoff A, Lippard SJ. Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proc Natl Acad Sci USA 2007; 104:10780-10785 (Pubitemid 47175178)
21. Zhang S, Trokowski R, Sherry AD. A paramagnetic CEST agent for imaging glucose by MRI. J Am Chem Soc 2003; 125:15288-15289 (Pubitemid 37532161)
22. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci USA 2003; 100:10435-10439
23. 13C. Br J Radiol 2003; 76[Spec No 2]:S118-S127
24. Bonner-Weir S. Chapter 39: The microvasculature of the pancreas, with emphasis on that of the islets of Langerhans. In: Go VLW, Dimagno EP, Gardner JD, et al., eds. The pancreas: biology, pathology, and disease. New York: Raven Press, Ltd., 1993:759-768
25. Bonner-Weir S. Anatomy of the islet of Langerhans. In: Samols E, ed. The endocrine pancreas. New York: Raven Press, Ltd., 1991:15-27
26. Brunicardi FC, Stagner J, Bonner-Weir S, et al. Microcirculation of the Islets of Langerhans: Long Beach Veterans Administration Regional Medical Education Center Symposium. Diabetes 1996; 45:385-392 (Pubitemid 26110241)
27. Lifson N, Kramlinger K, Mayrand R, Lender E. Blood flow to the rabbit pancreas with special reference to the islets of Langerhans. Gastroenterology 1980; 79:466-473 (Pubitemid 10056392)
28. Lifson N, Lassa C, Dixit P. Relation between blood flow and morphology in islet organ of rat pancreas. Am J Physiol 1985; 249:E43-E48 (Pubitemid 15031729)
29. Jansson L, Hellerstrom C. A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres. Acta Physiol Scand 1981; 113:371-374 (Pubitemid 12235760)
30. Carlsson PO, Sandler S, Jansson L. Pancreatic islet blood perfusion in the nonobese diabetic mouse: diabetes-prone female mice exhibit a higher blood flow compared with male mice in the prediabetic phase. Endocrinology 1998; 139:3534-3541 (Pubitemid 28512311)
31. Jansson L, Bodin B, Carlsson P. Changes in graft blood flow early after syngeneic rat pancreas-duodenum transplantation. Ups J Med Sci 2005; 110: 57-67 (Pubitemid 40342460)
32. Sandler S, Jansson L. Blood flow measurements in autotransplanted pancreatic islets of the rat. Impairment of the blood perfusion of the graft during hyperglycemia. J Clin Invest 1987; 80:17-21 (Pubitemid 17097511)
33. Carlsson PO, Bodin B, Andersson A, Jansson L. Carbon monoxide and pancreatic islet blood flow in the rat: inhibition of haem oxygenase does not affect islet blood perfusion. Scand J Clin Lab Invest 2006; 66:543-548 (Pubitemid 44764387)
34. Svensson A, Ostenson C, Efendic S, Jansson L. Effects of glucagon-like peptide-1 (7-36)amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats. Clin Sci 2007; 112:345-351 (Pubitemid 46392122)
35. Bogdanov AA Jr, Weissleder R, Frank HW, et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 1993; 187:701-706 (Pubitemid 23155697)
36. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998; 40:793-799 (Pubitemid 28543828)
37. Kwong KK, Chesler DA, Weisskoff RM, et al. MR perfusion studies with T1-weighted echo planar imaging. Magn Reson Med 1995; 34:878-887
38. Zaharchuk G, Bogdanov AA Jr, Marota JJ, et al. Continuous assessment of perfusion by tagging including volume and water extraction (CAPTIVE): a steady-state contrast agent technique for measuring blood flow, relative blood volume fraction, and the water extraction fraction. Magn Reson Med 1998; 40:666-678 (Pubitemid 28493642)
39. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997; 7:68-74 (Pubitemid 28365640)
40. Abramovitch R, Frenkiel D, Neeman M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 1998; 39:813-824 (Pubitemid 28189154)
41. Abramovitch R, Meir G, Neeman M. Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. Cancer Res 1995; 55:1956-1962
42. Atlas SW. Rationale and clinical indications for contrast agents in MR imaging of the brain and spine. J Comput Assist Tomogr 1993; 17[Suppl 1]:S1-S7 (Pubitemid 23150266)
43. Strugar J, Rothbart D, Harrington W, Criscuolo GR. Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 1994; 81: 560-566 (Pubitemid 24303282)
44. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988; 6:164-174
45. Fisel CR, Ackerman JL, Buxton RB, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991; 17:336-347
46. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994; 31:601-610
47. Padhani AR. Functional MRI for anticancer therapy assessment. Eur J Cancer 2002; 38:2116-2127 (Pubitemid 35223249)
48. Padhani AR. MRI for assessing antivascular cancer treatments. Br J Radiol 2003; 76[Spec No 1]:S60-S80
49. Sorensen AG, Tievsky AL, Ostergaard L, Weisskoff RM, Rosen BR. Contrast agents in functional MR imaging. J Magn Reson Imaging 1997; 7:47-55
50. Donahue KM, Weisskoff RM, Chesler DA, et al. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 1996; 36:858-867
51. Lewin M, Bredow S, Sergeyev N, Marecos E, Bogdanov AJ, Weissleder R. In vivo assessment of vascular endothelial growth factor-induced angiogenesis. Int J Cancer 1999; 83:798-802
52. Kim YR, Savellano MD, Weissleder R, Bogdanov A Jr. Steady-state and dynamic contrast MR imaging of human prostate cancer xenograft tumors: a comparative study. Technol Cancer Res Treat 2002; 1:489-495 (Pubitemid 36548525)
53. Kim YR, Yudina A, Figueiredo J, et al. Detection of early antiangiogenic effects in human colon adenocarcinoma xenografts: in vivo changes of tumor blood volume in response to experimental VEGFR tyrosine kinase inhibitor. Cancer Res 2005; 65:9253-9260 (Pubitemid 41507991)
54. Medarova Z, Castillo G, Dai G, Bolotin E, Bogdanov A, Moore A. Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes. Diabetes 2007; 56:2677-2682 (Pubitemid 350044908)
55. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci USA 2004; 101:12634-12639 (Pubitemid 39122075)
56. Turvey S, Swart E, Denis M, et al. Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 2005; 115:2454-2461; Epub 2005 Aug 18 (Pubitemid 41266207)
57. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230-238
58. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50:710-719
59. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318-1330 (Pubitemid 44465460)
60. Medarova Z, Moore A. Non-invasive detection of transplanted pancreatic islets. Diabetes Obes Metab 2008; 10:88-97
61. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 2006; 12:144-148
62. Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A. In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc 2006; 1:429-435
63. Evgenov NV, Medarova Z, Pratt J, et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 2006; 55:2419-2428 (Pubitemid 44872728)
64. Evgenov NV, Pratt J, Pantazopoulos P, Moore A. Effects of glucose toxicity and islet purity on in vivo magnetic resonance imaging of transplanted pancreatic islets. Transplantation 2008; 85:1091-1098 (Pubitemid 351590185)
65. Tai JH, Foster P, Rosales A, et al. Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes 2006; 55:2931-2938 (Pubitemid 44923630)
66. Medarova Z, Kumar M, Ng S, et al. Multifunctional magnetic nanocarriers for image-tagged siRNA delivery to intact pancreatic islets. Transplantation 2008; 86:1170-1177
67. Koblas T, Girman P, Berkova Z, et al. Magnetic resonance imaging of intrahepatically transplanted islets using paramagnetic beads. Transplant Proc 2005; 37:3493-3495 (Pubitemid 41659931)
68. Biancone L, Crich SG, Cantaluppi V, et al. Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation. NMR Biomed 2007; 20:40-48 (Pubitemid 46332439)
69. Barnett BP, Arepally A, Karmarkar PV, et al. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med 2007; 13:986-991 (Pubitemid 47222036)
70. Toso C, Vallee J, Morel P, et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 2008; 8:701-706 (Pubitemid 351287550)
71. Moore A, Medarova Z, Evgenov N, Dai G, Bonner-Weir S. Reply to "In vivo imaging of islet transplantation." Nat Med 2007; 13:773